Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
MIT scientist for over 50 years was a cherished mentor who published nearly 400 papers on topics from laser science to non-invasive biomedical diagnosis.